Enhancing the delayed emission proportion by incorporating bulky substituent at the 1-site of carbazole donors is proved to be effective and practical strategy to improve the EL performance of cyaphenine-carbazole type blue TADF emitters.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: